NCT03874897 2024-04-30Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.Peking UniversityPhase 1 Completed134 enrolled
NCT04478461 2020-11-13Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid TumorsMabwell (Shanghai) Bioscience Co., Ltd.Phase 1 Unknown21 enrolled